|
MUDENG expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.02799999623926E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.75479999922723E-08 |
| Normal-vs-Stage2 |
5.225400E-01 |
| Normal-vs-Stage3 |
1.66500035980732E-10 |
| Normal-vs-Stage4 |
3.41271455539527E-12 |
| Stage1-vs-Stage2 |
1.355990E-03 |
| Stage1-vs-Stage3 |
1.013520E-02 |
| Stage1-vs-Stage4 |
2.814900E-04 |
| Stage2-vs-Stage3 |
2.08429999999371E-05 |
| Stage2-vs-Stage4 |
2.64680000028328E-07 |
| Stage3-vs-Stage4 |
1.422810E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.23959953413078E-10 |
| Normal-vs-AfricanAmerican |
1.94756999999379E-05 |
| Normal-vs-Asian |
2.36180000001696E-07 |
| Caucasian-vs-AfricanAmerican |
6.092200E-01 |
| Caucasian-vs-Asian |
8.414200E-01 |
| AfricanAmerican-vs-Asian |
7.467000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.14890000425217E-08 |
| Normal-vs-Female |
3.33380000272498E-08 |
| Male-vs-Female |
6.398800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.60689999773834E-08 |
| Normal-vs-Age(41-60Yrs) |
2.13209999655462E-08 |
| Normal-vs-Age(61-80Yrs) |
1.80051999999487E-05 |
| Normal-vs-Age(81-100Yrs) |
6.757400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.663800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.193000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.583400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.637200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.527000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.393600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.419100E-03 |
| Classical-VS-Follicular |
7.52389999969516E-07 |
| Classical-VS-Other |
5.503200E-01 |
| Classical-VS-Normal |
1.14840026377294E-10 |
| Tall-VS-Follicular |
2.36260000452404E-09 |
| Tall-VS-Other |
4.300200E-01 |
| Tall-VS-Normal |
1.59290358681119E-11 |
| Follicular-VS-Other |
4.232200E-02 |
| Follicular-VS-Normal |
2.128600E-01 |
| Other-VS-Normal |
1.895850E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.51850000005027E-06 |
| Normal-vs-N1 |
1.05930042515467E-10 |
| N0-vs-N1 |
2.078500E-03 |
|
|
